Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.63
0.02 (3.75%)
At close: Aug 15, 2025, 3:59 PM
0.65
1.88%
After-hours: Aug 15, 2025, 07:40 PM EDT

Relmada Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.2 -0.31 -0.16 -0.63
PEG Ratio
0.01 0.01 0.01 -0.01
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.44 0.36 0.18 0.38
P/FCF Ratio
-0.3 -0.6 -0.25 -0.86
P/OCF Ratio
-0.3 -0.6 -0.25 -0.86
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a n/a
Quick Ratio
4.45 8.00 12.26 14.83
Current Ratio
4.45 8.00 12.26 14.83
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-2.25 -1.16 -1.12 -0.6
Return on Assets
-1.75 -1.01 -1.03 -0.56
Return on Invested Capital
-2.36 -1.21 -1.15 -0.6
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a